UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

(07) In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia™) as a potential nerve agent bioscavenger

Chemico-biological interactions, 2005-12, Vol.157, p.362-365

2005

Volltextzugriff (PDF)

O.071 Outcome of lip closure in UCLAP results (Baltic Cleft Network)

Journal of cranio-maxillo-facial surgery, 2008, Vol.36, p.S18-S18

2008

Volltextzugriff (PDF)

A (1)H NMR spectroscopic study of the biochemical effects of ifosfamide in the rat: evaluation of potential biomarkers

Biomarkers, 2000, Vol.5 (6), p.424-435

E M Lenzl J K Nicholson I D Wilson J A Timbrell

2000

Volltextzugriff (PDF)

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

The Lancet (British edition), 2009-11, Vol.374 (9702), p.1677-1686

2009

Volltextzugriff (PDF)

1058 ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY

Journal of hepatology, 2009, Vol.50, p.S385-S385

2009

Volltextzugriff (PDF)

1075 PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) ANALYSES OF TMC435 IN TREATMENT-NAIVE HEPATITIS C (HCV)-INFECTED PATIENTS IN THE OPERA-1 STUDY

Journal of hepatology, 2010, Vol.52, p.S416-S416

2010

Volltextzugriff (PDF)

1092P Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease

Annals of oncology, 2020-09, Vol.31, p.S740-S741

2020

Volltextzugriff (PDF)

11 IMPACT OF IL28B GENOTYPE AND PRETREATMENT SERUM IP-10 IN TREATMENT-NAIVE GENOTYPE-1 HCV PATIENTS TREATED WITH TMC435 IN COMBINATION WITH PEGINTERFERONa-2A AND RIBAVIRIN IN PILLAR STUDY

Journal of hepatology, 2011-03, Vol.54, p.S5-S6

2011

Volltextzugriff (PDF)

11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

Journal of hepatology, 2009-04, Vol.50, p.S7-S7

2009

Volltextzugriff (PDF)

116TiP Randomized, open-label, phase II study of botensilimab (BOT) alone and in combination with balstilimab (BAL) versus standard-of-care in patients with refractory metastatic colorectal cancer

Immuno-oncology technology, 2023-12, Vol.20, p.100588, Article 100588

2023

Volltextzugriff (PDF)

11LBA Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer

European journal of cancer (1990), 2014-11, Vol.50, p.199-199

2014

Volltextzugriff (PDF)

IL-12 Administered During Chlamydia psittaci Lung Infection in Mice Confers Immediate and Long-Term Protection and Reduces Macrophage Inflammatory Protein-2 Level and Neutrophil Infiltration in Lung Tissue

The Journal of immunology (1950), 1999-02, Vol.162 (4), p.2217-2226

1999

Volltextzugriff (PDF)

1221 TREATMENT OUTCOME AND RESISTANCE ANALYSIS IN HCV GENOTYPE 1 PATIENTS PREVIOUSLY EXPOSED TO TMC435 MONOTHERAPY AND RE-TREATED WITH TMC435 IN COMBINATION WITH PEGIFNα-2A/RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S482-S483

2011

Volltextzugriff (PDF)

125 Critical issues in the clinical development of oncolytic viruses – A regulatory perspective

European journal of cancer (1990), 2014-11, Vol.50, p.44-44

Schuessler-Lenz, M

2014

Volltextzugriff (PDF)

128P Real-world survival outcomes in MSS colorectal cancer(CRC) patients based on mesothelin(MSLN) expression

Annals of oncology, 2024-06, Vol.35, p.S59-S60

2024

Volltextzugriff (PDF)

130 Vaginal birth after cesarean (VBAC) success and uterine rupture among twin compared to singleton gestation

American journal of obstetrics and gynecology, 2024-01, Vol.230 (1), p.S87-S87

2024

Volltextzugriff (PDF)

1300P Treatment and clinical outcome in recurrent/refractory locally advanced NSCLC following chemoradiotherapy and consolidative durvalumab

Annals of oncology, 2023-10, Vol.34, p.S749-S749

2023

Volltextzugriff (PDF)

131TiP PRO B: A randomized controlled trial to evaluate the effect of a digital patient-reported outcome monitoring in metastatic breast cancer patients

Annals of oncology, 2021-05, Vol.32, p.S78

2021

Volltextzugriff (PDF)

O.135 Age-dependent results and complications of transpalatal distraction?

Journal of cranio-maxillo-facial surgery, 2006-09, Vol.34, p.38-38

2006

Volltextzugriff (PDF)

1358P Safety of tepotinib + EGFR TKI (osimertinib or gefitinib) in patients with EGFRm NSCLC

Annals of oncology, 2023-10, Vol.34, p.S780-S781

2023

Volltextzugriff (PDF)

1366TiP Tepotinib + osimertinib for EGFR-mutant NSCLC with resistance to first-line osimertinib due to MET amplification (METamp): INSIGHT 2

Annals of oncology, 2021-09, Vol.32, p.S1036-S1036

2021

Volltextzugriff (PDF)

1376 THE ASPIRE TRIAL: TMC435 IN TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE-1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGIFN/RBV TREATMENT

Journal of hepatology, 2011-03, Vol.54, p.S546-S546

2011

Volltextzugriff (PDF)

13C n.m.r. spectroscopy in living cells of Pseudomonas oleo vorans

Polymer (Guilford), 1997-10, Vol.38 (21), p.5313-5319

1997

Volltextzugriff (PDF)

13C n.m.r. spectroscopy in living cells of Pseudomonas oleovorans

Polymer (Guilford), 1997, Vol.38 (21), p.5313-5319

1997

Volltextzugriff (PDF)

1 – 25 von 5.493

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.542)
Mit Volltextzugriff
(4.500)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.846)
Life Sciences & Biomedicine
(2.002)
Humans
(1.477)
Male
(862)
Female
(783)
Biological And Medical Sciences
(688)
Physical Sciences
(619)
Animals
(545)
Middle Aged
(504)
Adult
(487)
Medical Sciences
(447)
Technology
(443)
Aged
(388)
Oncology
(335)
Physics
(300)
Fundamental And Applied Biological Sciences. Psychology
(276)
Neurosciences & Neurology
(207)
Exact Sciences And Technology
(204)
Biochemistry & Molecular Biology
(201)
Pharmacology & Pharmacy
(172)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(2.143)
EZB Free E-Journals
(2.118)
MEDLINE
(2.003)
Journals@Ovid Complete
(1.525)
Publisher website
(1.136)
Elsevier ScienceDirect Journals Complete
(918)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(681)
Wiley Online Library Journals Frontfile Complete
(643)
IngentaConnect Journals
(591)
Springer journals
(542)
Wiley Online Library Full Collection 2018
(439)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(362)
Ebook Central Perpetual and DDA
(295)
eBooks on EBSCOhost
(277)
Thieme Connect (journals)
(221)
Nature International Weekly Journal of Science
(184)
Oxford Journals
(167)
IEEE Electronic Library (IEL)
(142)
JSTOR Complete Journals
(137)
SpringerLink Series
(129)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(37)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

(07) In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia™) as a potential nerve agent bioscavenger

O.071 Outcome of lip closure in UCLAP results (Baltic Cleft Network)

A (1)H NMR spectroscopic study of the biochemical effects of ifosfamide in the rat: evaluation of potential biomarkers

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

1022: THE ROLE OF PROBE-BASED CONFOCAL ENDOMICROSCOPY (PCLE) IN THE DIAGNOSIS OF SUSTAINED CLINICAL COMPLETE RESPONSE UNDER WATCH-AND-WAIT STRATEGY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED RECTAL ADENOCARCINOMA

1058 ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY

1075 PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) ANALYSES OF TMC435 IN TREATMENT-NAIVE HEPATITIS C (HCV)-INFECTED PATIENTS IN THE OPERA-1 STUDY

1092P Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease

11 IMPACT OF IL28B GENOTYPE AND PRETREATMENT SERUM IP-10 IN TREATMENT-NAIVE GENOTYPE-1 HCV PATIENTS TREATED WITH TMC435 IN COMBINATION WITH PEGINTERFERONa-2A AND RIBAVIRIN IN PILLAR STUDY

11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

116TiP Randomized, open-label, phase II study of botensilimab (BOT) alone and in combination with balstilimab (BAL) versus standard-of-care in patients with refractory metastatic colorectal cancer

11LBA Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer

IL-12 Administered During Chlamydia psittaci Lung Infection in Mice Confers Immediate and Long-Term Protection and Reduces Macrophage Inflammatory Protein-2 Level and Neutrophil Infiltration in Lung Tissue

1221 TREATMENT OUTCOME AND RESISTANCE ANALYSIS IN HCV GENOTYPE 1 PATIENTS PREVIOUSLY EXPOSED TO TMC435 MONOTHERAPY AND RE-TREATED WITH TMC435 IN COMBINATION WITH PEGIFNα-2A/RIBAVIRIN

125 Critical issues in the clinical development of oncolytic viruses – A regulatory perspective

128P Real-world survival outcomes in MSS colorectal cancer(CRC) patients based on mesothelin(MSLN) expression

130 Vaginal birth after cesarean (VBAC) success and uterine rupture among twin compared to singleton gestation

1300P Treatment and clinical outcome in recurrent/refractory locally advanced NSCLC following chemoradiotherapy and consolidative durvalumab

131TiP PRO B: A randomized controlled trial to evaluate the effect of a digital patient-reported outcome monitoring in metastatic breast cancer patients

O.135 Age-dependent results and complications of transpalatal distraction?

1358P Safety of tepotinib + EGFR TKI (osimertinib or gefitinib) in patients with EGFRm NSCLC

1366TiP Tepotinib + osimertinib for EGFR-mutant NSCLC with resistance to first-line osimertinib due to MET amplification (METamp): INSIGHT 2

1376 THE ASPIRE TRIAL: TMC435 IN TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE-1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGIFN/RBV TREATMENT

13C n.m.r. spectroscopy in living cells of Pseudomonas oleo vorans

13C n.m.r. spectroscopy in living cells of Pseudomonas oleovorans

Suchergebnisse filtern